Breast Cancer Awareness Month As Breast Cancer Awareness Month begins, Paxman is raising awareness of a critical and often ...

Expanded production facilities and new warehouses will boost efficiency, reduce lead times and enhance regional supply chains ...

Wayne, PA – Veranova, a global leader in the development and manufacturing of specialist and complex APIs for the ...

IntroductionPharmacovigilance, a critical component of the pharmaceutical industry, involves the detection, assessment, ...

LONDON, October 10 th 2024, - CNX Therapeutics Limited (“CNX Therapeutics”), a speciality pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines, ...

PIDs to include ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency and PTEN deficiency, with prevalence approximately five times that of APDS Leiden, the Netherlands, October 10, 2024: ...

Vapourtec creates 'mini review' showcasing key publications A recent ‘mini review’ created by Vapourtec demonstrates the scope and potential of flow biocatalysis as well as showcasing several ...

Oxford, England, 10 October 2024 - MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD) in obesity-related ...

Copenhagen, Denmark - FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision cancer surgery, today announced the submission of the Clinical Trial Application (CTA) ...

Antag Therapeutics, a leading biopharmaceutical company focused on targeting the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor to pioneer novel treatments for obesity, today announced ...

Deep expertise in leading drug discovery programs across oncology, neuroscience and epigeneticsWill drive advancement of Curve’s rich pipeline of first-in-class therapeutic assets Builds on recent ...

Paris, October 9, 2024. Sanofi advances its ambition to protect all infants from respiratory syncytial virus (RSV) disease with new Beyfortus (nirsevimab) data to be presented at the Infectious ...